Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22656234 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: methylprednisolone;   Drug: temozolomide

Study has passed its completion date and status has not been verified in more than two years.